Expanding Sisram's Ecosystem Offerings and Increasing Direct Sales Reach
HONG KONG, Aug. 24, 2023 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused branding, including energy-based devices, injectables, aesthetics and digital dentistry, personal care, and more, today announced its unaudited consolidated interim results for the six months ended June 30, 2023 (the "Reporting Period").
FINANCIAL HIGHLIGHTS
KEY ACHIEVEMENTS
Business development
Research and development
Brand awareness
INTERIM DIVIDEND
STRATEGY & OUTLOOK
Continue to implement the strategy of direct sales and open new direct operations in strategic markets
Throughout 2023, the Group's strategic endeavors focused on cultivating the North American and Chinese markets, while also exploring growth opportunities in Europe and the rest of the Asia Pacific regions. In addition, a primary focus lies in seamlessly integrating and optimizing direct sales channels in China, with a strong emphasis on boosting market penetration. This strategic move aims to enhance Sisram's customer engagement and improve its market position.
Expanding Sisram's offerings, customized to consumers' unique needs
Sisram will continue expanding its offerings through its unique wellness ecosystem, providing partners and consumers with effective and trustworthy solutions for their needs. In addition to traditional sectors, the company is actively establishing a presence in distinct markets and enhancing the product's market impact within specialized niches. On a global scale, China serves as the pioneering market for Sisram Medical within the wellness ecosystem. The company is devoted to ensuring a successful entry into the Chinese market for its injectable products such as Daxxify and IBSA products, while concurrently assembling a professional team to facilitate the commercialization preparations.
Enhance brand presence among end-consumers
Sisram sees elevating brand awareness among end-consumers as a key step in bolstering brand recognition and meeting demand for the Company's solutions. In North America, those efforts extend to empowering a post-sales team to further stimulate sales activities, as well as promoting Sisram's wellness ecosystem. Within the Chinese market, a major priority is heightening brand awareness for the LMNT personal care line and revealing the potential of the wellness ecosystem.
Mr. Liu Yi, Chairman and Executive Director of Sisram, commented: "Following the first half of 2023, we've achieved significant milestones in strategic deployment. We are also acutely aware of the untapped potential within the convergence of health and beauty. In the second half of the year, our dedication remains resolute as we intensify efforts to elevate our brand influence and refine the quality and expansion of our business and services. This strategic focus will be particularly directed towards our key markets, Asia Pacific, and North America. Additionally, our unwavering commitment extends to the Chinese market. As a core market, we're capitalizing on distribution-to-direct sales shift, deepening cultivation, and driving sustainable growth."
Mr. Lior Dayan, CEO of Sisram and Alma, said: "The first half of 2023 was pivotal for Sisram, as we continue our transition from a product-centered approach to a customer-centric approach and present significant achievements in building our unique wellness ecosystem. Our strategic expansion, introduction of cutting-edge products, and investment in brand recognition will pave the way for our continued successful growth as we expand globally and gain market share. By prioritizing the customer journey and delivering exceptional experiences, we are confident that our long-term collaborations with our valuable partners will contribute to the Group's ongoing growth and success in the evolving wellness industry, and we anticipate even greater advances in the near future."
About Sisram Medical Ltd
Sisram Medical Ltd (1696.HK) is a global consumer wellness group, featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused branding, including energy-based devices, injectables, aesthetics, digital dentistry, personal care, and more. The company is majority-owned by Fosun Pharma, one of China's leading healthcare groups. On September 19, 2017, Sisram Medical went public, becoming the first Israeli company ever to trade on the Main Board of the Hong Kong Exchange.
Sisram Medical – Enhancing Quality of Life